Chemistry:Adimolol
From HandWiki
Short description: Chemical compound
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C25H29N3O3 |
| Molar mass | 419.525 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Adimolol (developmental code name MEN-935) is antihypertensive agent which acts as a non-selective α1-, α2-, and β-adrenergic receptor antagonist.[1]
Synthesis

The reaction between 1-Naphthyl glycidyl ether [2461-42-9] (1) and 3-(3-amino-3-methylbutyl)-1H-benzimidazol-2-one [64928-58-1] (2) gives adimolol (3).
References
- ↑ "Interactions of MEN 935 (adimolol), a long acting beta- and alpha-adrenolytic antihypertensive agent, with postsynaptic alpha-adrenoceptors in different isolated blood vessels--influence of angiotensin II". Naunyn-Schmiedeberg's Archives of Pharmacology 333 (3): 277–83. July 1986. doi:10.1007/bf00512941. PMID 3020439.
- ↑ "Adimolol Hydrochloride Hydrate.". Drugs of the Future 11: 9. 1986. doi:10.1358/dof.1986.011.01.62036.
- ↑ Koppe H, Mentrup A, Renth EO, Schromm K, Hoefke W, Muacevic G, US patent 4255430, issued 1981, assigned to Boehringer Ingelheim Gmbh.

